Literature DB >> 8867057

Paucity of P-zones in striatal grafts prohibit commencement of clinical trials in Huntington's disease.

P Brundin1, R A Fricker, N Nakao.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8867057     DOI： 10.1016/0306-4522(95)00162-x

Source DB:  PubMed          Journal:  Neuroscience        ISSN： 0306-4522            Impact factor:   3.590


× No keyword cloud information.
  4 in total

Review 1.  Therapeutic effects of stem cells in rodent models of Huntington's disease: Review and electrophysiological findings.

Authors:  Sandra M Holley; Talia Kamdjou; Jack C Reidling; Brian Fury; Dane Coleal-Bergum; Gerhard Bauer; Leslie M Thompson; Michael S Levine; Carlos Cepeda
Journal:  CNS Neurosci Ther       Date:  2018-03-06       Impact factor: 5.243

2.  Neural transplants in patients with Huntington's disease undergo disease-like neuronal degeneration.

Authors:  F Cicchetti; S Saporta; R A Hauser; M Parent; M Saint-Pierre; P R Sanberg; X J Li; J R Parker; Y Chu; E J Mufson; J H Kordower; T B Freeman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-20       Impact factor: 11.205

3.  The Current Status of Neural Grafting in the Treatment of Huntington's Disease. A Review.

Authors:  Ruwani Wijeyekoon; Roger A Barker
Journal:  Front Integr Neurosci       Date:  2011-12-07

Review 4.  Differentiation of pluripotent stem cells into striatal projection neurons: a pure MSN fate may not be sufficient.

Authors:  Amy E Reddington; Anne E Rosser; Stephen B Dunnett
Journal:  Front Cell Neurosci       Date:  2014-12-02       Impact factor: 5.505
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.